Pradaxa maker reaches $650 million settlement
RIDGEFIELD, Conn., May 29 (UPI) --Pharmaceutical company Boehringer Ingelheim announced Wednesday it had reached a $650 million settlement in state and federal cases in the U.S. regarding the blood thinner Pradaxa. In a statement released by the company, senior vice president and general counsel of... Sign in to see full entry.
![Associated Content](https://www.associatedcontent.com/user/8835/mandaleesrc="http://www.associatedcontent.com/images/house_ads/cp-sp6.gif" border="0"></a>){kind=link}